Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Biochemistry, |
RCV001265628 | SCV001443791 | pathogenic | Familial cancer of breast | criteria provided, single submitter | case-control | ||
Ambry Genetics | RCV004951438 | SCV005522140 | pathogenic | Hereditary cancer-predisposing syndrome | 2024-11-08 | criteria provided, single submitter | clinical testing | The c.848_849delGC pathogenic mutation, located in coding exon 7 of the TP53 gene, results from a deletion of two nucleotides at nucleotide positions 848 to 849, causing a translational frameshift with a predicted alternate stop codon (p.R283Hfs*22). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |